| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection | Tsou H.-H; | HUNG-CHIH YANG ; | Hsiao C.-F; | Hsiung C.A; | Liu T.-W; | Chuang M.-H; | Wu H.-Y; | Hsu Y.-T; | Tsui C.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group | Journal of the Formosan Medical Association | 4 | ||
| 2018 | Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection | HUNG-CHIH YANG ; | Tsou H.-H; | Pei S.-N; | Chang C.-S; | Chen J.-H; | Yao M; | Lin S.-J; | Lin J; | Yuan Q; | Xia N; | Liu T.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group | Journal of Hepatology | 45 |
